SpineGuard マネジメント

マネジメント基準チェック /24

We currently do not have sufficient information about the CEO.

主要情報

Pierre Jérôme

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	15.8yrs
CEOの所有権	n/a
経営陣の平均在職期間	15.8yrs
取締役会の平均在任期間	12yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Pierre Jérôme

15.8yrs

在職期間

€194,919

報酬

Mr. Pierre Jérôme co-founded SpineGuard SA in January 2009 and has been its Chairman of the Board since March 14, 2018 and also serves as its Chief Executive Officer since February 13, 2020. Mr. Jérôme ser...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Pierre Jérôme	Co-Founder	15.8yrs	€194.92k	データなし
Stéphane Bette	Co-Founder	15.8yrs	€155.52k	データなし
Maurice Bourlion	Co-Inventor & Director	no data	データなし	データなし
Anne-Charlotte Millard	Chief Financial Officer	1.4yrs	データなし	データなし
Patricia Lempereur	Vice President of International Sales & Global Marketing	no data	データなし	データなし

15.8yrs

平均在職期間

経験豊富な経営陣: ALSGD's management team is seasoned and experienced (15.8 years average tenure).

取締役

名称	ポジション	在職期間	報酬	所有権
Pierre Jérôme	Co-Founder	15yrs	€194.92k	データなし
Stéphane Bette	Co-Founder	7yrs	€155.52k	データなし
Maurice Bourlion	Co-Inventor & Director	15yrs	データなし	データなし
Alexia Perouse	Independent Director	9yrs	データなし	データなし

12.0yrs

平均在職期間

経験豊富なボード: ALSGD's board of directors are seasoned and experienced ( 12 years average tenure).

SpineGuard マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

SpineGuard SA Announces CFO Changes

Less than half of directors are independent

Less than half of directors are independent

Recent updates

SpineGuard Obtains FDA Clearance for Commercial Release of its PsiFGuard

Would SpineGuard (EPA:ALSGD) Be Better Off With Less Debt?

New major risk - Share price stability

Spineguard Obtains EC-MDR Certification and Launches Its Threaded Pediguard for Anterior Spine Surgery in Europe

SpineGuard Files Its 510K Dossier in the Us for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion

SpineGuard SA Provides Sales Guidance for the Second Half of 2024

New major risk - Shareholder dilution

Full year 2023 earnings released

New minor risk - Financial data availability

SpineGuard SA to Report Fiscal Year 2023 Results on Apr 17, 2024

New major risk - Market cap size

Does SpineGuard (EPA:ALSGD) Have A Healthy Balance Sheet?

New major risk - Financial position

First half 2023 earnings released

New major risk - Revenue and earnings growth

SpineGuard Strengthens its Intellectual Property with a New Patent Granted in Brazil

SpineGuard SA announced that it expects to receive €7.5 million in funding from Nice & Green SA

SpineGuard SA Announces CFO Changes

Full year 2022 earnings released

SpineGuard SA to Report Fiscal Year 2022 Results on Apr 13, 2023

Less than half of directors are independent

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

First half 2022 earnings released

Is SpineGuard (EPA:ALSGD) A Risky Investment?

Less than half of directors are independent

SpineGuard Obtains FDA Clearance for Commercial Release of Its “Threaded Pediguard” in Anterior Approach Spine Surgery

SpineGuard Files its “510K” Dossier for the Clearance of its “Threaded PediGuard” in Anterior Approach Spine Surgery

First half 2021 earnings released

SpineGuard Announces INMETRO Certification for the 'DSG Connect' in Brazil

Full year 2020 earnings released

SpineGuard SA announced that it expects to receive €9.5 million in funding from Nice & Green SA

SpineGuard SA Obtains FDA Clearance for Commercial Release of Its New “DSG Connect” Platform in the USA

New 90-day high: €1.78

SpineGuard Collaborates With the European Project Functional Accurate RObotic Surgery

SpineGuard Sa Strengthens Its Intellectual Property with A New Patent Granted in Japan

SpineGuard SA to Report Fiscal Year 2020 Results on Apr 08, 2021

New 90-day high: €0.45

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

First half earnings released

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

マネジメント基準チェック /24